Policybazaar History & Founding Timeline

Policybazaar's investment in DocPrime as a broad health services marketplace—doctor consultations, diagnostics, pharmacy—expanded well beyond the insurance-adjacent health services that would have been most synergistic with the core insurance business, consuming management attention and capital in a competitive health services market where Practo and PharmEasy had established strong positions, without achieving the user engagement scale that justified the investment level.

Policybazaar was slow to build a systematic corporate group insurance business, allowing relationship-based insurance brokers and bancassurance channels to maintain dominance in the enterprise insurance segment for years before Policybazaar for Business was launched with appropriate investment—missing the faster growth and higher-margin economics of corporate accounts during a period when company resources were instead concentrated on retail consumer acquisition.

Policybazaar publicly discussed international expansion—particularly into the UAE and Middle East—multiple years before the UAE regulatory approval was obtained in 2023, creating investor expectations that were not met on the communicated timelines and contributing to post-IPO credibility challenges during the 2022 market correction period when delivery against stated growth plans was being heavily scrutinised.